New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 24, 2014
09:16 EDTLOGI, FTNT, JNJ, TRIP, SRPT, UA, SKX, VDSI, QCOM, DNKN, CAT, ANGI, ONVO, F, GM, FBOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Facebook (FB), up 7.6%... Ford (F), up 1.4%... Skechers (SKX), up 8%... Under Armour (UA), up 8.5%... VASCO (VDSI), up 16.6%... Logitech (LOGI), up 14.4%... Fortinet (FTNT), up 9%. ALSO HIGHER: Organovo (ONVO), up 19.6% after entering a 3D bio-printed tissue agreement with a unit of J&J (JNJ). DOWN AFTER EARNINGS: General Motors (GM), down 2.4%... Dunkin' Brands (DNKN), down 7.8%... TripAdvisor (TRIP), down 9.7%... Qualcomm (QCOM), down 5.5%... Caterpillar (CAT), down 2.8%. ALSO LOWER: Angie's List (ANGI), down 18% after Q2 report last night, at least seven downgrades of stock this morning... Sarepta (SRPT), down 6.3% after terminating Chief Scientific Officer Arthur Krieg.
News For FB;GM;F;ONVO;ANGI;CAT;DNKN;QCOM;VDSI;SKX;UA;SRPT;TRIP;JNJ;FTNT;LOGI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | all recent news | >>
October 17, 2014
16:31 EDTGMGeneral Motors announces $12.5B revolving credit facility
Subscribe for More Information
16:01 EDTFBOptions Update; October 17, 2014
iPath S&P 500 VIX Short-Term Futures down 1.75 to 38.58 Option volume leaders: AAPL TSLA TWTR AMZN FB NFLX GILD CLF PBR according to Track Data.
14:50 EDTSRPTBARDA asks labs to ramp up Zmapp production, Reuters says
Subscribe for More Information
14:39 EDTFFord to hold a conference call
Subscribe for More Information
10:37 EDTJNJOptions with decreasing implied volatility: ATLS JNJ XLNX JNK HYG
Subscribe for More Information
09:46 EDTSRPTSarepta soars after publication of Ebola drug candidate data
Subscribe for More Information
09:17 EDTSRPTOn The Fly: Pre-market Movers
Subscribe for More Information
08:57 EDTJNJPharmacyclics price target raised to $188 from $185 at Roth Capital
Subscribe for More Information
08:51 EDTJNJPharmacyclics announces European approval for Imbruvica
Subscribe for More Information
08:02 EDTJNJCovidien granted preliminary injunction against Ethicon's Harmonic ACE+7
Subscribe for More Information
October 16, 2014
18:36 EDTSRPTOn The Fly: After Hours Movers
Subscribe for More Information
18:16 EDTSRPTSarepta up 10.6% following publication of Ebola phase 1 clinical study
16:13 EDTSRPTSarepta announces publication of Ebola, Marburg Phase I clinical study results
Sarepta Therapeutics announced the publication of results from two single ascending-dose studies that demonstrated no clinical or toxicologic safety concerns with the company’s drug candidates for the treatment of Ebola and Marburg virus, respectively. AVI-6002 for the treatment of Ebola is a combination therapy of two phosphorodiamidate morpholino oligomers, which target the viral matrix proteins VP24 and VP35, respectively. AVI-6003 for the treatment of Marburg is a combination therapy of two PMOs, which target the viral proteins VP24 and NP, respectively. These drug candidates use Sarepta’s advanced and proprietary PMOplus chemistry, which is also the basis of the company’s clinical-stage influenza drug candidate, AVI-7100. Results from previous viral challenge studies of AVI-6002 and AVI-6003 in non-human primates demonstrated prevention of disease development and death following exposure to Ebola or Marburg virus. Subsequent animal studies demonstrated that for each combination therapy, only one oligomer contributed to efficacy, and therefore, the lead drug candidates for Ebola and Marburg have since become the single compounds AVI-7537 and AVI-7288.
14:58 EDTCATArmy poised to order more Stryker vehicles, Defense News says
Subscribe for More Information
14:47 EDTJNJRoche in pact with Pharmacyclics to evaluate Imbruvica, Gazyva combo
Subscribe for More Information
12:04 EDTGMStocks with call strike movement; ABBV GM
AbbVie (ABBV) January 60 call option implied volatility decreased 5% to 29, General Motors (GM) March 33 call option implied volatility decreased 4% to 39 according to IVolatility.
11:17 EDTCATTitan downturn warning seen as negative for Deere, AGCO
Subscribe for More Information
09:41 EDTCATTitan outlook negative for AGCO, Deere, says Wells Fargo
Subscribe for More Information
09:39 EDTFBActive equity options trading on open
Subscribe for More Information
06:34 EDTF, GMChina to punish automakers that miss fuel standards, Reuters reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use